Term ends Jan 28, 2036 · High confidence
20-year base term ends Jan 28, 2036
Held by Novo Nordisk A/S
Filed Sep 26, 2019 as application 16/584,634 · Granted Jun 8, 2021
Base term plus 24 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2016
2036
Clock starts
Jan 28, 2016
Jan 28, 2016
Term ends
Jan 28, 2036
Jan 28, 2036
Granted
Jun 8, 2021
Jun 8, 2021
base term
fee events
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
24
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,464,999, US 10,669,330.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 24 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 28, 2016, when application 15/009,662, the earliest non-provisional in its chain, was filed (this one was filed Sep 26, 2019) | Jan 28, 2036 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +24 days, USPTO patent term adjustment record | Feb 21, 2036 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,464,999, US 10,669,330) | capped to Jan 28, 2036 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jan 28, 2036 | High confidence |
This family
| Application 15/009,662 | Abandoned not computed | not computed |
| US 10,464,999 | In force Jan 2036 | Jan 2036 |
| US 10,669,330 | In force Jan 2036 | Jan 2036 |
| US 11,028,158 | this patent Jan 2036 | Jan 2036 |
| US 11,912,759 | In force Jan 2036 | Jan 2036 |
| Application 18/414,178 | Pending not computed | not computed |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 29, 2021 Reel 57645, frame 334 | Prothena Biosciences Limited | Neotope Neuroscience Limited | Assignment of Assignor's Interest |
| Oct 19, 2021 Reel 57859, frame 344 | Prothena Biosciences Limited | Neotope Neuroscience Limited | Corrective Assignment to Correct the Assignee's City Previously Recorded at Reel: 057645 Frame: 0334. Assignor(S) Hereby Confirms the Assignment . |
| Jan 4, 2023 Reel 62278, frame 323 | Neotope Neuroscience Limited | Novo Nordisk A/S | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jan 2036
Term ends Jan 28, 2036. Maintenance fees still fall due before then
Note
The 24 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 10,464,999, US 10,669,330.
Citations
13
later US patents cite this one
That is top 25% of utility patents granted in 2021 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.